Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Constriction, Pathological

3,3',5-triiodothyroacetic acid has been researched along with Constriction, Pathological in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Research Excerpts

ExcerptRelevanceReference
"None of the patients had stent restenosis, aneurysms, acute thrombosis, pregnancy, life expectancy less than 1 year, or below-the-knee artery occlusion."2.84[Efficacy of drug-coated balloon and common balloon for treatment of superficial femoral artery and popliteal artery arteriosclerosis obliterans: prospective randomized controlled triac]. ( Gu, JP; Lou, WS; Lu, JY; Wang, T; Xu, WJ, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, JY1
Gu, JP1
Xu, WJ1
Lou, WS1
Wang, T1

Trials

1 trial available for 3,3',5-triiodothyroacetic acid and Constriction, Pathological

ArticleYear
[Efficacy of drug-coated balloon and common balloon for treatment of superficial femoral artery and popliteal artery arteriosclerosis obliterans: prospective randomized controlled triac].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2017, 03-20, Volume: 37, Issue:3

    Topics: Angioplasty, Balloon; Arteriosclerosis Obliterans; Constriction, Pathologic; Femoral Artery; Humans;

2017